Cumberland Pharmaceuticals CPIX Share Repurchase Program, Authorized, Amount
Share Repurchase Program, Authorized, Amount at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept srt:StockRepurchaseProgramAuthorizedAmount1.
The source filing: Cumberland Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001087294-26-000062
On July 13, 2026, the Company's Board of Directors authorized and declared a special cash dividend of $1.50 per share of common stock payable in cash to the Company’s shareholders of record as of July 23, 2026. The dividend was paid on July 31, 2026 in the amount of $22.5 million. In addition to the special dividend, the Board authorized an open-market share repurchase program of up to $5 million in Cumberland shares of common stock over time. This replaces the previous share repurchase program established in January 2019 that allowed $10 million of share repurchases, of which $2.1 million remained available. The timing and actual number of shares repurchased pursuant the Company’s repurchase program will be determined by management depending on a variety of factors, including stock price, trading volume, market conditions, and other general business considerations. Several Board members will also be establishing new share purchase plans to increase their holdings in the Company.
Item 1. Financial Statements (Unaudited)
FAQ
- What is Cumberland Pharmaceuticals's share repurchase program, authorized, amount?
- Cumberland Pharmaceuticals (CPIX) reported share repurchase program, authorized, amount of $5 in Q2 2026.
- What does share repurchase program, authorized, amount mean?
- Share Repurchase Program, Authorized, Amount
Ask your AI about Cumberland Pharmaceuticals's share repurchase program, authorized, amount.
Connect your AI assistant and compare it to peers, right in your chat.
